The average US life expectancy decreased by nearly 2 years from 2018 to 2020, with minority groups affected the most; the FDA will add a rare heart inflammation warning to fact sheets for the Pfizer and Moderna COVID-19 vaccines; a series of expansions to the Medicaid safety-net program is reportedly in consideration.
According to a study published Thursday in BMJ, the average US life expectancy decreased by nearly 2 years from 2018 to 2020, with the worst decline found in minority groups such as Black and Hispanic people. Largely due to the pandemic, NPR reports that the drop in average US life expectancy, from 78.7 years in 2018 to 76.9 years in 2020, marks the largest decrease observed since World War II (WWII). In addition to COVID-19, factors associated with decreased longevity included disruptions in health care, disruptions in chronic disease management, and the behavioral health crisis.
Yesterday, an official from the FDA said the agency is rapidly moving to add a warning to fact sheets for Pfizer's and Moderna’s mRNA COVID-19 vaccines amid reports of a rare risk in developing inflammatory heart conditions. As reported by POLITICO, cases of myocarditis and pericarditis in vaccine recipients aged 30 and younger were noted to be of particular interest. As these rare cases appear to resolve on their own, CDC advisers are urging teens and young adults to still seek vaccination, noting that the benefits of COVID-19 protection outweigh the risks.
As reported by Kaiser Health News, the Biden administration was noted to be quietly engineering a series of expansions to the Medicaid safety net program that would work to provide coverage for millions of low-income Americans and boost enrollment. With some efforts to boost the program funded by the COVID-19 relief bill passed in March, the Biden administration is seeking to further add to the surge in enrollment reported in Medicaid and the Children’s Health Insurance Program. Notably, Medicaid-funded services that have not been traditionally offered in the past, such as food and housing, may be pursued as well.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More